These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31535835)
1. The Prevalence of Pseudomonas Aeruginosa Infection Over a Ten-Year Period in Children with Cystic Fibrosis. Al Shidhani K; O’Reilly R; Javadpour S; O’Sullivan N; McNally P; Cox DW Ir Med J; 2019 Jun; 112(6):946. PubMed ID: 31535835 [TBL] [Abstract][Full Text] [Related]
2. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569 [TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre. Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902 [TBL] [Abstract][Full Text] [Related]
4. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis. Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Proesmans M; Balinska-Miskiewicz W; Dupont L; Bossuyt X; Verhaegen J; Høiby N; de Boeck K Eur Respir J; 2006 May; 27(5):937-43. PubMed ID: 16707392 [TBL] [Abstract][Full Text] [Related]
6. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A; J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995 [TBL] [Abstract][Full Text] [Related]